Some multinational pharmaceutical companies are reviewing to acknowledge the financial costs

It is known that there is a subtle opinion gap between multinational pharmaceutical companies to the demand of pharmaceutical wholesale industry who requires improving low-margin business policies.

In the past year, the Korea Pharmaceutical Wholesaler Association persistently asked for re-distribution of margin reflecting financial costs to multinational pharmaceutical companies.

Since ...